Skip to main content

Agah Ramtin's Form 4 filing

RenovoRx, Inc.RNXT · filed Jun 9, 2022

Accession no.
0001493152-22-016226
Filed
Jun 9, 2022
Trade date
Mar 16-Jun 7, 2022
Filing delay
85 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market purchases total $10.0K. It was filed 85 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Agah RamtinCIK 0001862617Director, Officer (Chief Medical Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 16, 2022Common StockGGiftDisposed−975,000$0.00$01,295Direct
Mar 16, 2022Common StockGGiftAcquired+975,000$0.00$0975,000Indirect
Jun 7, 2022Common StockPPurchaseAcquired+5,182$1.93+$10,001.266,477Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)